Recalls & Warnings October 13, 2016 Soylent Recalls Bars As It Investigates Complaints of Gastrointestinal Issues On October 12, 2016, Soylent announced it is halting all Soylent Bar purchases and shipments while it investigates consumer complaints of gastrointestinal issues, such as vomiting and diarrhea, after consuming the bars
and a two-adult IV safety pilot at 10 mg and 20 mg (Lee, Walker & Ayadi, 2025)
The rate of infusion for the second dose may range from 15 minutes (for patients in extremis) to two hours, as clinically indicated
But now, for the first time, a panel of the worlds top diabetes experts convened to release a consensus statement with recommendations on the safe use of GLP-1 receptor agonists and GLP-1/GIP medications for people living with type 1 diabetes, led by Dr